Sky Foundation, Inc. Market Research Report
Background
Overview
Sky Foundation, Inc. is a non-profit organization dedicated to raising awareness and funding innovative research for the early detection and treatment of pancreatic cancer. Established in 2008 by Sheila Sky Kasselman, a pancreatic cancer survivor, the foundation aims to increase survival rates and save lives through early detection methods.
Mission and Vision
The foundation's mission is to support scientists and clinicians in the United States who are pursuing research in early detection, prevention, or treatment of pancreatic cancer. By awarding seed-money grants, Sky Foundation helps researchers advance their work to attract further funding from institutions like the National Institutes of Health.
Industry Significance
Pancreatic cancer is projected to be the second most deadly cancer in the United States by 2020, yet it ranks eighth in federal research funding. Sky Foundation addresses this gap by providing essential support to researchers, thereby contributing to the advancement of medical knowledge and potential breakthroughs in pancreatic cancer treatment.
Key Strategic Focus
Core Objectives
- Funding Research: Provide seed grants to researchers focusing on early detection, prevention, and treatment of pancreatic cancer.
- Raising Awareness: Organize events to educate the public and support those diagnosed with pancreatic cancer.
Areas of Specialization
- Early Detection Methods: Supporting research aimed at identifying pancreatic cancer at earlier, more treatable stages.
- Innovative Treatments: Funding studies exploring novel therapeutic approaches for pancreatic cancer.
Key Technologies Utilized
While specific technologies are not detailed, the foundation's focus on early detection and treatment suggests support for advanced diagnostic tools and cutting-edge therapeutic methods.
Primary Markets or Conditions Targeted
The foundation primarily targets pancreatic cancer, a condition with a high mortality rate and limited early detection options.
Financials and Funding
Funding History
Sky Foundation operates as a 501(c)(3) non-profit organization, relying on donations from individuals, corporations, and foundations. Its financial statements are publicly available through GuideStar, providing transparency and accountability.
Total Funds Raised
Specific figures for total funds raised are not provided in the available sources.
Recent Funding Rounds
As a non-profit, Sky Foundation does not engage in traditional funding rounds but instead conducts fundraising campaigns and events to support its mission.
Notable Investors
The foundation's supporters include a diverse group of individuals and organizations committed to advancing pancreatic cancer research.
Intended Utilization of Capital
Funds are primarily used to award grants to researchers, organize awareness events, and support operational expenses.
Pipeline Development
Key Pipeline Candidates
The foundation funds various research projects across multiple institutions, including:
- Henry Ford Health: Research on pancreatic cancer.
- University of California, San Francisco: Studies related to pancreatic cancer.
- New York University: Research initiatives focusing on pancreatic cancer.
Stages of Clinical Trials or Product Development
Specific stages of clinical trials or product development for these projects are not detailed in the available sources.
Target Conditions
All funded projects aim to address pancreatic cancer, focusing on early detection and novel therapies.
Relevant Timelines for Anticipated Milestones
Detailed timelines for research milestones are not provided in the available sources.
Technological Platform and Innovation
Proprietary Technologies
The foundation does not develop proprietary technologies but supports research that may lead to innovative diagnostic and therapeutic methods for pancreatic cancer.
Significant Scientific Methods
While specific methodologies are not detailed, the foundation's focus suggests support for advanced research techniques in oncology.
AI-Driven Capabilities
There is no specific information indicating the use of AI-driven capabilities in the foundation's supported research.
Leadership Team
Executive Profiles
- Annie Dalton Flores: Executive Director with over eight years of leadership in pancreatic cancer advocacy.
- Jamie Guyor: Business Manager with more than 13 years of philanthropic experience, focusing on operational efficiency and program support.
- Shannon Crone: President of the Governing Board, leading strategic growth and community impact initiatives.
Key Contributions or Roles Within the Company
Each leader plays a pivotal role in advancing the foundation's mission through strategic direction, operational management, and community engagement.
Competitor Profile
Market Insights and Dynamics
The non-profit sector focusing on pancreatic cancer research is characterized by a need for increased funding and awareness. Organizations like Sky Foundation play a crucial role in bridging the gap between limited federal funding and the urgent need for research advancements.
Competitor Analysis
While specific competitors are not detailed, other organizations in the field include the Pancreatic Cancer Action Network and the Lustgarten Foundation, both of which also focus on research funding and awareness.
Strategic Collaborations and Partnerships
Sky Foundation collaborates with leading research institutions such as Henry Ford Health, University of California, and New York University to fund and support pancreatic cancer research.
Operational Insights
The foundation's focus on early detection and treatment of pancreatic cancer positions it as a key player in a niche but critical area of oncology research.
Strategic Opportunities and Future Directions
Strategic Roadmap
Sky Foundation aims to expand its funding capabilities, increase public awareness, and support a broader range of research initiatives to improve pancreatic cancer outcomes.
Future Business Directions
The foundation plans to enhance its grant programs, foster new partnerships, and advocate for increased research funding at the federal level.
Opportunities for Expansion
Opportunities include broadening the scope of funded research, increasing community engagement, and expanding educational initiatives.
Current Strengths
The foundation's established relationships with top research institutions and its clear focus on early detection and treatment provide a strong foundation for future growth and impact.
